GSK
NuCana appoints GSK oncology head
December 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana
Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors. Paoletti has been …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
Takeda: we’re working on Ebola too
November 24, 2014Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya
The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …
GSK tests mHealth trial solutions
November 19, 2014Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth
GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …
GSK tops pharma league for access
November 17, 2014Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines
GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …
NICE backs GSK’s leukaemia drug Arzerra following price cut
November 4, 2014Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia
NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …
GSK mulls $27 billion ViiV sell-off
October 23, 2014Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV
After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …
GSK: Ebola vaccines will come ‘too late’
October 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp
GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …
Novartis says three executives departing firm
October 9, 2014Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines
Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …
New chairman to take seat at GSK
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, gent, philip hampton
The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …
GSK fined, executives face jail sentence in Chinese bribery case
September 19, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery, sex tape
China has fined Britain’s largest pharma firm GlaxoSmithKline $490 million (£297m) for corruption after a year-long investigation into claims it …
GSK melanoma drug sees quick NICE nod
September 18, 2014Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer
NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
China: a dangerous game that pharma must play
September 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt
Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …
GSK Ebola vaccine fast-tracked into human trials
August 28, 2014Sales and Marketing Africa, Ebola, GSK, WHO, zmapp
GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
